Technical Analysis for QTRX - Quanterix Corporation

Grade Last Price % Change Price Change
F 11.03 0.05% 0.01
QTRX closed down 0.36 percent on Wednesday, November 20, 2024, on 1.33 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.05%
NR7 Range Contraction 0.05%
NR7-2 Range Contraction 0.05%
Narrow Range Bar Range Contraction 0.05%
Doji - Bullish? Reversal 0.05%
Wide Bands Range Expansion 0.05%
Down 3 Days in a Row Weakness 0.05%
Down 4 Days in a Row Weakness 0.05%
Down 5 Days in a Row Weakness 0.05%
Oversold Stochastic Weakness 0.05%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High 5 minutes ago
Outside Day 5 minutes ago
Fell Below Previous Day's Low 5 minutes ago
Down 1% 5 minutes ago
Up 2% 5 minutes ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Disease Infectious Diseases Inflammation Urology Biomarkers Cardiology Neurology Quality Of Life Digital Health

Is QTRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.7
52 Week Low 10.5
Average Volume 423,250
200-Day Moving Average 16.45
50-Day Moving Average 12.90
20-Day Moving Average 13.19
10-Day Moving Average 12.97
Average True Range 0.81
RSI (14) 33.33
ADX 25.95
+DI 16.72
-DI 33.22
Chandelier Exit (Long, 3 ATRs) 13.25
Chandelier Exit (Short, 3 ATRs) 13.29
Upper Bollinger Bands 16.14
Lower Bollinger Band 10.25
Percent B (%b) 0.13
BandWidth 44.59
MACD Line -0.36
MACD Signal Line 0.07
MACD Histogram -0.4246
Fundamentals Value
Market Cap 416.88 Million
Num Shares 37.8 Million
EPS -1.02
Price-to-Earnings (P/E) Ratio -10.80
Price-to-Sales 7.89
Price-to-Book 2.60
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.52
Resistance 3 (R3) 11.52 11.36 11.43
Resistance 2 (R2) 11.36 11.23 11.36 11.40
Resistance 1 (R1) 11.19 11.16 11.28 11.19 11.38
Pivot Point 11.03 11.03 11.07 11.03 11.03
Support 1 (S1) 10.86 10.90 10.95 10.86 10.66
Support 2 (S2) 10.70 10.83 10.70 10.64
Support 3 (S3) 10.53 10.70 10.61
Support 4 (S4) 10.53